vs

Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and ADVANCED DRAINAGE SYSTEMS, INC. (WMS). Click either name above to swap in a different company.

ADVANCED DRAINAGE SYSTEMS, INC. is the larger business by last-quarter revenue ($693.4M vs $397.6M, roughly 1.7× Guardian Pharmacy Services, Inc.). ADVANCED DRAINAGE SYSTEMS, INC. runs the higher net margin — 13.5% vs 5.3%, a 8.2% gap on every dollar of revenue.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

Advanced Drainage Systems, Inc. (ADS) is an American company that designs, manufactures and markets polypropylene and polyethylene pipes, plastic leach field chambers and systems, septic tanks and accessories, storm retention/detention and septic chambers, polyvinyl chloride drainage structures, fittings, and water filters and water separators. It is the largest maker of high-density polyethylene pipe in the United States. It is headquartered in Hilliard, Ohio. In 2020, 93% of the company's s...

GRDN vs WMS — Head-to-Head

Bigger by revenue
WMS
WMS
1.7× larger
WMS
$693.4M
$397.6M
GRDN
Higher net margin
WMS
WMS
8.2% more per $
WMS
13.5%
5.3%
GRDN

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
GRDN
GRDN
WMS
WMS
Revenue
$397.6M
$693.4M
Net Profit
$20.9M
$93.6M
Gross Margin
21.5%
37.4%
Operating Margin
7.7%
19.7%
Net Margin
5.3%
13.5%
Revenue YoY
0.4%
Net Profit YoY
15.3%
EPS (diluted)
$1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRDN
GRDN
WMS
WMS
Q4 25
$397.6M
$693.4M
Q3 25
$377.4M
$850.4M
Q2 25
$344.3M
$829.9M
Q1 25
$329.3M
$615.8M
Q4 24
$690.5M
Q3 24
$314.4M
$782.6M
Q2 24
$815.3M
Q1 24
$653.8M
Net Profit
GRDN
GRDN
WMS
WMS
Q4 25
$20.9M
$93.6M
Q3 25
$9.8M
$156.0M
Q2 25
$9.0M
$143.9M
Q1 25
$9.4M
$77.2M
Q4 24
$81.2M
Q3 24
$-122.0M
$130.4M
Q2 24
$161.4M
Q1 24
$94.8M
Gross Margin
GRDN
GRDN
WMS
WMS
Q4 25
21.5%
37.4%
Q3 25
19.8%
40.0%
Q2 25
19.8%
39.8%
Q1 25
19.5%
36.7%
Q4 24
35.0%
Q3 24
19.4%
37.6%
Q2 24
40.8%
Q1 24
38.5%
Operating Margin
GRDN
GRDN
WMS
WMS
Q4 25
7.7%
19.7%
Q3 25
4.3%
26.3%
Q2 25
3.7%
24.8%
Q1 25
3.9%
19.0%
Q4 24
18.4%
Q3 24
-33.3%
23.9%
Q2 24
27.7%
Q1 24
20.7%
Net Margin
GRDN
GRDN
WMS
WMS
Q4 25
5.3%
13.5%
Q3 25
2.6%
18.3%
Q2 25
2.6%
17.3%
Q1 25
2.9%
12.5%
Q4 24
11.8%
Q3 24
-38.8%
16.7%
Q2 24
19.8%
Q1 24
14.5%
EPS (diluted)
GRDN
GRDN
WMS
WMS
Q4 25
$1.19
Q3 25
$1.99
Q2 25
$1.84
Q1 25
$0.99
Q4 24
$1.04
Q3 24
$1.67
Q2 24
$2.06
Q1 24
$1.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRDN
GRDN
WMS
WMS
Cash + ST InvestmentsLiquidity on hand
$65.6M
$1.0B
Total DebtLower is stronger
$0
Stockholders' EquityBook value
$217.9M
$1.9B
Total Assets
$412.7M
$4.1B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRDN
GRDN
WMS
WMS
Q4 25
$65.6M
$1.0B
Q3 25
$36.5M
$812.9M
Q2 25
$18.8M
$638.3M
Q1 25
$14.0M
$463.3M
Q4 24
$488.9M
Q3 24
$37.2M
$613.0M
Q2 24
$541.6M
Q1 24
$490.2M
Total Debt
GRDN
GRDN
WMS
WMS
Q4 25
$0
Q3 25
Q2 25
Q1 25
$1.3B
Q4 24
Q3 24
$34.3M
Q2 24
Q1 24
$1.3B
Stockholders' Equity
GRDN
GRDN
WMS
WMS
Q4 25
$217.9M
$1.9B
Q3 25
$195.5M
$1.8B
Q2 25
$179.7M
$1.7B
Q1 25
$163.2M
$1.5B
Q4 24
$1.5B
Q3 24
$133.9M
$1.4B
Q2 24
$1.3B
Q1 24
$1.2B
Total Assets
GRDN
GRDN
WMS
WMS
Q4 25
$412.7M
$4.1B
Q3 25
$390.0M
$4.1B
Q2 25
$356.3M
$3.9B
Q1 25
$334.0M
$3.7B
Q4 24
$3.6B
Q3 24
$348.0M
$3.5B
Q2 24
$3.4B
Q1 24
$3.3B
Debt / Equity
GRDN
GRDN
WMS
WMS
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
0.83×
Q4 24
Q3 24
0.26×
Q2 24
Q1 24
1.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRDN
GRDN
WMS
WMS
Operating Cash FlowLast quarter
$34.6M
$269.3M
Free Cash FlowOCF − Capex
$183.6M
FCF MarginFCF / Revenue
26.5%
Capex IntensityCapex / Revenue
12.4%
Cash ConversionOCF / Net Profit
1.65×
2.88×
TTM Free Cash FlowTrailing 4 quarters
$577.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRDN
GRDN
WMS
WMS
Q4 25
$34.6M
$269.3M
Q3 25
$28.2M
$234.9M
Q2 25
$19.9M
$275.0M
Q1 25
$17.6M
$41.2M
Q4 24
$189.9M
Q3 24
$166.9M
Q2 24
$183.4M
Q1 24
$17.7M
Free Cash Flow
GRDN
GRDN
WMS
WMS
Q4 25
$183.6M
Q3 25
$24.2M
$176.4M
Q2 25
$222.4M
Q1 25
$-5.3M
Q4 24
$135.7M
Q3 24
$112.4M
Q2 24
$125.7M
Q1 24
$-29.8M
FCF Margin
GRDN
GRDN
WMS
WMS
Q4 25
26.5%
Q3 25
6.4%
20.7%
Q2 25
26.8%
Q1 25
-0.9%
Q4 24
19.7%
Q3 24
14.4%
Q2 24
15.4%
Q1 24
-4.6%
Capex Intensity
GRDN
GRDN
WMS
WMS
Q4 25
12.4%
Q3 25
1.1%
6.9%
Q2 25
6.3%
Q1 25
7.6%
Q4 24
7.9%
Q3 24
7.0%
Q2 24
7.1%
Q1 24
7.3%
Cash Conversion
GRDN
GRDN
WMS
WMS
Q4 25
1.65×
2.88×
Q3 25
2.87×
1.51×
Q2 25
2.21×
1.91×
Q1 25
1.86×
0.53×
Q4 24
2.34×
Q3 24
1.28×
Q2 24
1.14×
Q1 24
0.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRDN
GRDN

Segment breakdown not available.

WMS
WMS

Reportable Segment Aggregation Before Other Operating Segment$557.3M80%
Other$85.5M12%
Pipe$35.5M5%
Allied Products And Other$15.0M2%

Related Comparisons